{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:53Z","timestamp":1790630693310,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003715","name":"KRIBB","doi-asserted-by":"publisher","award":["KGM5522113"],"award-info":[{"award-number":["KGM5522113"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"KRIBB","doi-asserted-by":"publisher","award":["KGS1082113"],"award-info":[{"award-number":["KGS1082113"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"KRIBB","doi-asserted-by":"publisher","award":["KGS1432113"],"award-info":[{"award-number":["KGS1432113"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003704","name":"Korea Research Institute of Chemical Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2020R1A2C2012347"],"award-info":[{"award-number":["NRF- 2020R1A2C2012347"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.phymed.2021.153695","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T17:16:58Z","timestamp":1627838218000},"page":"153695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypes"],"prefix":"10.1016","volume":"92","author":[{"given":"Miri","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwook","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeyong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansook","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Nyoung","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Bae","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hyo","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungchan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153695_bib0001","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.abb.2010.12.024","article-title":"Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)","volume":"507","author":"Adayev","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phymed.2021.153695_bib0002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nbd.2005.12.006","article-title":"DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects","volume":"22","author":"Ahn","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phymed.2021.153695_bib0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid as a probable human cancer hazard in herbal remedies: a review","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.phymed.2021.153695_bib0004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2021.153695_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2011.0415","article-title":"Epilepsy in children with Down syndrome","volume":"13","author":"Arya","year":"2011","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.phymed.2021.153695_bib0006","first-page":"1","article-title":"Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity","volume":"62","author":"Becker","year":"1999","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.phymed.2021.153695_bib0007","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/np400856h","article-title":"Acridone alkaloids from Glycosmis chlorosperma as DYRK1A inhibitors","volume":"77","author":"Beniddir","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2021.153695_bib0008","first-page":"131","article-title":"DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3","author":"Bhansali","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2021.153695_bib0009","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/bdra.20294","article-title":"National estimates and race\/ethnic-specific variation of selected birth defects in the United States, 1999-2001","volume":"76","author":"Canfield","year":"2006","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.phymed.2021.153695_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajmg.c.30097","article-title":"Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome","volume":"142C","author":"Capone","year":"2006","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.phymed.2021.153695_bib0011","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1523\/JNEUROSCI.3406-07.2007","article-title":"Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome","volume":"27","author":"Chakrabarti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phymed.2021.153695_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molcel.2013.09.009","article-title":"Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle","volume":"52","author":"Chen","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2021.153695_bib0013","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/np000063v","article-title":"Aristolactams and dioxoaporphines from Fissistigma balansae and Fissistigma oldhamii","volume":"63","author":"Chia","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2021.153695_bib0014","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1055\/s-2006-947196","article-title":"Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro","volume":"72","author":"Chia","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2021.153695_bib0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.5483\/BMBRep.2018.51.10.051","article-title":"Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body","volume":"51","author":"Choi","year":"2018","journal-title":"BMB Rep"},{"key":"10.1016\/j.phymed.2021.153695_bib0016","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1016\/j.bmcl.2009.04.020","article-title":"Synthesis of aristolactam analogues and evaluation of their antitumor activity","volume":"19","author":"Choi","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2021.153695_bib0017","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/14786419.2012.688044","article-title":"Antioxidant and antimicrobial activities of aporphinoids and other alkaloids from the bark of Annona salzmannii A. DC. (Annonaceae)","volume":"27","author":"Costa","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.phymed.2021.153695_bib0018","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phymed.2021.153695_bib0019","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ncb2829","article-title":"Riquiqui and minibrain are regulators of the hippo pathway downstream of Dachsous","volume":"15","author":"Degoutin","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2021.153695_bib0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/14786419.2014.905563","article-title":"Isolation, structural elucidation and anti-inflammatory activity of astragalin, (-)hinokinin, aristolactam I and aristolochic acids (I & II) from Aristolochia indica","volume":"28","author":"Desai","year":"2014","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.phymed.2021.153695_bib0021","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/jm501994d","article-title":"10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A","volume":"58","author":"Falke","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A Protein, a promising therapeutic target to improve cognitive deficits in down syndrome","volume":"8","author":"Feki","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.phymed.2021.153695_bib0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2007.09.015","article-title":"Episodic-like memory in Ts65Dn, a mouse model of Down syndrome","volume":"188","author":"Fernandez","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phymed.2021.153695_bib0024","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","article-title":"Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice","volume":"22","author":"Fotaki","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2021.153695_bib0025","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","article-title":"Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation","volume":"276","author":"Gockler","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.phymed.2021.153695_bib0026","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in down syndrome and the development of alzheimer's disease neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.phymed.2021.153695_bib0027","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3590497","article-title":"Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A","volume":"359","author":"Himpel","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.phymed.2021.153695_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/8c2c8644-1beb-4410-8bef-c388b7256738","article-title":"Minibrain\/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF\/NPY pathway in Drosophila and mammals","volume":"8","author":"Hong","year":"2012","journal-title":"PLos Genet."},{"key":"10.1016\/j.phymed.2021.153695_bib0029","first-page":"929","article-title":"Cytotoxic alkaloids from leaves and twigs of Dasymaschalon sootepense","volume":"9","author":"Hongthong","year":"2014","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.phymed.2021.153695_bib0030","first-page":"1315","article-title":"DYRK1A kinase inhibitors with emphasis on cancer","volume":"12","author":"Ionescu","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0031","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0896-6273(02)00706-7","article-title":"Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila","volume":"34","author":"Jackson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.phymed.2021.153695_bib0032","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0033","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/ejhg.2015.71","article-title":"DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies","volume":"23","author":"Ji","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.phymed.2021.153695_bib0034","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1248\/bpb.32.1433","article-title":"Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids","volume":"32","author":"Jung","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2021.153695_bib0035","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/acsmedchemlett.0c00346","article-title":"Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2021.153695_bib0036","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0021-9924(95)00026-7","article-title":"Linguistic and cognitive ability of adults with Down syndrome and mental retardation of unknown etiology","volume":"29","author":"Kernan","year":"1996","journal-title":"J. Commun. Disord."},{"key":"10.1016\/j.phymed.2021.153695_bib0037","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05920","article-title":"The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells","volume":"4","author":"Khor","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.phymed.2021.153695_bib0038","first-page":"839","article-title":"A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition","volume":"9","author":"Kim","year":"2016","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.phymed.2021.153695_bib0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phymed.2021.153695_bib0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/b303648k","article-title":"Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities","volume":"20","author":"Kumar","year":"2003","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phymed.2021.153695_bib0041","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2174\/092986710790712183","article-title":"Natural polyphenols that display anticancer properties through inhibition of kinase activity","volume":"17","author":"Lamoral-Theys","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0042","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb1710","article-title":"Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling","volume":"10","author":"Lee","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2021.153695_bib0043","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","article-title":"Phosphorylation affects the ability of tau protein to promote microtubule assembly","volume":"259","author":"Lindwall","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040639","article-title":"Meridianins and lignarenone B as potential GSK3beta inhibitors and inductors of structural neuronal plasticity","volume":"10","author":"Llorach-Pares","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2021.153695_bib0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","article-title":"Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs","volume":"121","author":"Lochhead","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2021.153695_bib0046","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mrdd.1025","article-title":"Down syndrome and Alzheimer's disease: a link between development and aging","volume":"7","author":"Lott","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.phymed.2021.153695_bib0047","doi-asserted-by":"crossref","first-page":"e13000","DOI":"10.1111\/acel.13000","article-title":"Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease","volume":"18","author":"Melchior","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.phymed.2021.153695_bib0048","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1039\/c3np70114j","article-title":"Naturally occurring aristolochic acid analogues and their toxicities","volume":"31","author":"Michl","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phymed.2021.153695_bib0049","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-7847.120524","article-title":"Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids","volume":"7","author":"Moloudizargari","year":"2013","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.phymed.2021.153695_bib0051","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.3390\/molecules16097357","article-title":"Antibacterial activity of Aristolochia brevipes against multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Navarro-Garcia","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2021.153695_bib73","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035634","article-title":"Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.","author":"Nguyen","year":"2018","journal-title":"Disease models and mechanisms"},{"key":"10.1016\/j.phymed.2021.153695_bib0052","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2021.153695_bib0053","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2021.153695_bib0054","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1101\/gr.169101","article-title":"A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster","volume":"11","author":"Reiter","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.phymed.2021.153695_bib0055","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2021.153695_bib0056","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153695_bib0057","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-4159.2010.06769.x","article-title":"Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease","volume":"115","author":"Ryu","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2021.153695_bib0058","article-title":"Neurologic complications of Down syndrome: a systematic review","author":"Santoro","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.phymed.2021.153695_bib0059","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice","volume":"56","author":"Sato","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153695_bib0060","first-page":"e52434","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.phymed.2021.153695_bib0061","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/bbrc.1996.1135","article-title":"Cloning of a human homolog of the Drosophila minibrain\/rat Dyrk gene from \"the Down syndrome critical region\" of chromosome 21","volume":"225","author":"Shindoh","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2021.153695_bib0062","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/geno.1996.0636","article-title":"Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome \"critical region\"","volume":"38","author":"Song","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.phymed.2021.153695_bib74","doi-asserted-by":"crossref","DOI":"10.4161\/cc.29104","article-title":"The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation","author":"Soppa","year":"2014","journal-title":"Cell cycle"},{"key":"10.1016\/j.phymed.2021.153695_bib0063","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/mgg3.334","article-title":"Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits","volume":"5","author":"Stringer","year":"2017","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.phymed.2021.153695_bib0065","first-page":"537","article-title":"Phenolic aristolactams from leaves and stems of Aristolochia chilensis. Bolet\u00edn Latinoamericano y del Caribe de","volume":"12","author":"Urzua","year":"2013","journal-title":"Plantas Medicinales y Arom\u00e1ticas"},{"key":"10.1016\/j.phymed.2021.153695_bib0066","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/mp.2015.5","article-title":"Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID","volume":"21","author":"van Bon","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phymed.2021.153695_bib0067","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1111\/febs.12411","article-title":"Mechanism of dual specificity kinase activity of DYRK1A","volume":"280","author":"Walte","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.phymed.2021.153695_bib0068","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2021.153695_bib0069","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4049\/jimmunol.1901065","article-title":"Ca(2+)-Calcineurin Axis-Controlled NFAT Nuclear Translocation Is Crucial for Optimal T Cell Immunity in an Early Vertebrate","volume":"204","author":"Wei","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2021.153695_bib0070","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","article-title":"The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase","volume":"355","author":"Woods","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.phymed.2021.153695_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245962","article-title":"How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition-The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine","volume":"25","author":"Wurzlbauer","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2021.153695_bib0072","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","article-title":"Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells","volume":"30","author":"Yabut","year":"2010","journal-title":"J. Neurosci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:30:24Z","timestamp":1778776224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":72,"alternative-id":["S0944711321002385"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153695","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypes","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153695"}}